Policy | December 03, 2025
US & UK reach historic pharma pricing pact
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
Datamatics will automate the Medication Administration Record process by integrating its intelligent automation products, TruBot and TruCap+
mRNA-4359 advances to phase 2 following encouraging results in checkpoint inhibitor-resistant Melanoma
Panacea Biotec receives acceptance from CMSS for supply of bOPV
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
The portfolio includes branded injectable cephalosporines for infectious diseases
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
